Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom

Biochimica et Biophysica Acta - General Subjects

Volumn 1760, Issue 9, 2006, Pages 1450-1457

  Tamarozzi, M B ^a   Soares, S G ^a   Marcussi, S ^a   Giglio, J R ^a   Barbosa, J E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bothropic venom; Myotoxin; Phage Display; Phospholipase A2; scFv

Indexed keywords

CREATINE KINASE; MYOTOXIN; PHOSPHOLIPASE A2; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HEMOLYSIS; MALE; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; SNAKE; TOXIN ANALYSIS;

ANIMALS; ANTIBODIES; BLOOD COAGULATION; BOTHROPS; CROTALID VENOMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEART; HUMANS; KINETICS; MICE; PEPTIDE FRAGMENTS; PHOSPHOLIPASES A; RECOMBINANT PROTEINS; SOLUBILITY;

BOTHROPS; BOTHROPS JARARACUSSU;

EID: 33748521989     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.04.008     Document Type: Article

References (34)

1. Gutiérrez J.M. Understanding snake venoms. 50 years of research in Latin America. Rev. Biol. Trop. 50 (2002) 377-394
2. Gutiérrez J.M., and Lomonte B. Phospholipase A(2), myotoxins from Bothrops snake venoms. Toxicon 33 (1995) 1405-1424
3. Soares A.M., Fontes M.R.M., and Giglio J.R. Phospholipase A(2) myotoxins from Bothrops snake venoms: structure-function relationship. Curr. Org. Chem. 8 (2004) 1677-1690
4. Dennis E.A. The growing phospholipase A(2) superfamily of signal transduction enzymes. Trends Biochem. Sci. 22 (1997) 1-2
5. Ohno M., Chijiwa T., Oda-Ueda N., Ogawa T., and Hattori S. Molecular evolution of myotoxic phospholipases A(2) from snake venom. Toxicon 42 (2003) 841-854
6. Soares A.M., and Giglio J.R. Chemical modifications of phospholipases A(2) from snake venoms: effects on catalytic and pharmacological properties. Toxicon 42 (2003) 855-868
7. Ownby C.L., de Araújo H.S.S., White S.P., and Fletcher J.E. Lysine 49 phospholipase A(2) proteins. Toxicon 37 (1999) 411-445
8. Homsi-Brandeburgo M.I., Queiroz L.S., Santo-Neto H., Rodrigues-Simioni L., and Giglio J.R. Fractionation of Bothrops jararacussu snake venom: partial chemical characterization and biological activity. Toxicon 26 (1988) 615-627
9. Andrião-Escarso S.H., Soares A.M., Rodrigues V.M., Ângulo Y., Diaz C., Lomonte B., Gutièrrez J.M., and Giglio J.R. Myotoxic phospholipases A(2) in Bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu. Biochimie 82 (2000) 755-763
10. Roberto P.G., Kashima S., Marcussi S., Pereira J.O., Astolfi-Filho S., Nomizo A., Giglio J.R., Fontes M.R., Soares A.M., and Franca S.C. Cloning and identification of a complete cDNA coding for a bactericidal and antitumoral acidic phospholipase A2 from Bothrops jararacussu venom. Protein J. 23 (2004) 273-285
11. Andrião-Escarso S.H., Soares A.M., Fontes M.R.M., Fuly A.L., Correa F.M.A., Rosa J.C., Greene L.J., and Giglio J.R. Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A(2) from Bothrops jararacussu snake venom. Biochem. Pharmacol. 64 (2002) 723-732
12. Roberto P.G., Kashima S., Soares A.M., Chioato L., Faca V.M., Fuly A.L., Astolfi-Filho S., Pereira J.O., and Franca S.C. Cloning and expression of an acidic platelet aggregation inhibitor phospholipase A2 cDNA from Bothrops jararacussu venom gland. Protein Expr. Purif. 37 (2004) 102-108
13. Magro A.J., Murakami M.T., Marcussi S., Soares A.M., Arni R.K., and Fontes M.R. Crystal structure of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 in the monomeric and dimeric states: insights into its oligomeric state. Biochem. Biophys. Res. Commun. 323 (2004) 24-31
14. Rivière G., Choumet V., Audebert F., Sabouraud A., Debray M., Scherrman J.M., and Bon C. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. J. Pharmacol. Exp. Ther. 281 (1997) 1-8
15. Winter G., and Milstein C. Man-made antibodies. Nature 349 (1991) 293-299
16. McCafferty J., Griffiths A.D., Winter G., and Chiswell D.J. Phage antibodies-filamentous phage displaying antibody variable domains. Nature 348 (1990) 552-554
17. Hoogenboom H.R., Griffiths A.D., Johnson K.S., Chiswell D.J., Hudson P., and Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19 (1991) 4133-4137
18. McGuinness B.T., Walter G., FitzGerald K., Schuler P., Mahoney W., Duncan A.R., and Hoogenboom H.R. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments. Nat. Biotechnol. 14 (1996) 1149-1154
19. Soares A.M., Andriao-Escarso S.H., Angulo Y., Lomonte B., Gutièrrez J.M., Marangoni S., Toyama M.H., Arni R.K., and Giglio J.R. Structural and functional characterization of myotoxin I, a Lys49 phospholipase A(2) homologue from Bothrops moojeni (Caissaca) snake venom. Arch. Biochem. Biophys. 373 (2000) 7-15
20. Soares A.M., Guerra-Sa R., Borja-Oliveira C.R., Rodrigues V.M., Rodrigues-Simioni L., Rodrigues V., Fontes M.R.M., Lomonte B., Gutièrrez J.M., and Giglio J.R. Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A(2) homologue from Bothrops neuwiedi pauloensis venom. Arch. Biochem. Biophys. 378 (2000) 201-209
21. Soares A.M., Marcussi S., Stabeli R.G., Franca S.C., Giglio J.R., Ward R.J., and Arantes E.C. Structural and functional analysis of BmjMIP, a phospholipase A2 myotoxin inhibitor protein from Bothrops moojeni snake plasma. Biochem. Biophys. Res. Commun. 302 (2003) 193-200
22. Bethell G.S., Ayers J.S., Hancock W.S., and Hearn M.T. Novel method of activation of crosslinked agaroses with 1,1′-carbonyldiimidazole which gives a matrix for affinity chromatography devoid of additional charged groups. J. Biol. Chem. 254 (1979) 2572-2574
23. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., and Winter G. Bypassing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222 (1991) 581-597
24. M.B. Tamarozzi, Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom (M.Sc. Dissertation). University of Sao Paulo, 2005.
25. A.O. Mota-Junior, Inhibition of a new serineprotease isolated from B. jararacussu snake venom using a GRIFFIN.1 library of recombinant antibody [M.Sc. Dissertation]. University of Sao Paulo, 2005.
26. McCafferty J., Hoogenboomn H.R., and Chiswell D.J. Antibody Engineering, A Practical Approach. 1st ed. (1996), Oxford Univ. Press, Oxford
27. Pereira M.F., Novello J.C., Cintra A.C., Giglio J.R., Landucci E.T., Oliveira B., and Marangoni S. The amino acid sequence of bothropstoxin-II, an Asp-49 myotoxin from Bothrops jararacussu (Jararacucu) venom with low phospholipase A2 activity. J. Protein Chem. 17 (1998) 381-386
28. Andrião-Escarso S.H., Soares A.M., Fontes M.R.M., Fuly A.L., Corrêa F.M.A., Rosa J.C., Greene L.J., and Giglio J.R. Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 from Bothrops jararacussu snake venom. Biochem. Pharmacol. 64 (2002) 723-732
29. McElhiney J., Drever M., Lawton L.A., and Porter A.J. Rapid isolation of a single-chain antibody against the cyanobacterial toxin microcystin-LR by phage display and its use in the immunoaffinity concentration of microcystins from water. Appl. Environ. Microbiol. 68 (2002) 5288-5295
30. de Lorenzo C., Palmer D.B., Piccoli R., Ritter M.A., and D'alessio G. A new human antitumor immunoreagent specific for ErbB2. Clin. Cancer Res. 8 (2002) 1710-1719
31. Díaz C., Gutièrrez J.M., and Lomonte B. Isolation and characterization of basic myotoxic phospholipases A2 from Bothrops godmani (Godman's pit viper) snake venom. Arch. Biochem. Biophys. 298 (1992) 135-142
32. Kini R.M. Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms. Toxicon 45 (2005) 1147-1161
33. Boffa M.C., and Boffa G.A. A phospholipase A2 with anticoagulant activity: II. Inhibition of the phospholipid activity in coagulation. Biochim. Biophys. Acta 429 (1976) 839-852
34. Blackwell G.J., and Flower R.J. Inhibition of phospholipase. Br. Med. Bull. 39 (1983) 260-264